drugset / Trial / NCT00002949

Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis

NCT00002949

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy with may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy with vinorelbine and paclitaxel plus radiation therapy in treating patients with advanced cancer arising in the pelvis.

Timeline

Start
1996-07
Primary completion
2000-11
Completion
2001-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 20 mg/m2
Subject Vinorelbine Small molecule 10 mg/m2
Subject Vinorelbine Small molecule 15 mg/m2
Subject Vinorelbine Small molecule 20 mg/m2
Subject Vinorelbine Small molecule 25 mg/m2